Education
About Us
Working with TipRanks
Follow Us
Equasens Société (DE:PHF)
:PHF
PHF Stock Chart & Stats
Day’s Range― - ―
52-Week Range€31.15 - €65.70
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€773.55M
Enterprise ValueN/A
Total Cash (Recent Filing)€63.33M
Total Debt (Recent Filing)€53.00M
Price to Earnings (P/E)16.9
Beta0.46
Next Earnings
Sep 26, 2025EPS EstimateN/A
Next Dividend Ex-Date
Jul 02, 2025Dividend Yield2.47%
Share Statistics
EPS (TTM)1.27
Shares Outstanding15,174,125
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio-1.20
Price to Book (P/B)2.77
Price to Sales (P/S)0.00
P/FCF Ratio20.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€75.00Price Target Upside84.50% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Equasens News
Bulls Say, Bears Say
Bulls Say
AcquisitionsThe recently acquired accounts payables management platform Digipharmacie grew 27% in FY24 and should continue to benefit from its SaaS model.
Financial PerformanceEquasens had a strong Q1 with 5.9% organic growth, which should help the company regain some of the lost confidence from the investment community.
Market ExpansionItaly is a bright spot with organic growth of 13.3% and +50 new client wins, showing that investments in the sales force are paying off.
Bears Say
Market ExpectationsEquasens saw its 4Q24 revenue come in 1% ahead of expectations.
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.20%
Mutual Funds
― Other Institutional Investors
97.16% Public Companies and
Individual Investors
PHF FAQ
What was Equasens Société’s price range in the past 12 months?
Equasens Société lowest stock price was €31.15 and its highest was €65.70 in the past 12 months.
What is Equasens Société’s market cap?
Equasens Société’s market cap is €773.55M.
When is Equasens Société’s upcoming earnings report date?
Equasens Société’s upcoming earnings report date is Sep 26, 2025 which is in 112 days.
How were Equasens Société’s earnings last quarter?
Equasens Société released its earnings results on Mar 28, 2025. The company reported €1.267 earnings per share for the quarter, beating the consensus estimate of N/A by €1.267.
Is Equasens Société overvalued?
According to Wall Street analysts Equasens Société’s price is currently Undervalued.
Does Equasens Société pay dividends?
Equasens Société pays a Annually dividend of €1.25 which represents an annual dividend yield of 2.47%. See more information on Equasens Société dividends here
What is Equasens Société’s EPS estimate?
Equasens Société’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Equasens Société have?
Equasens Société has 15,174,125 shares outstanding.
What happened to Equasens Société’s price movement after its last earnings report?
Equasens Société reported an EPS of €1.267 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.132%.
Which hedge fund is a major shareholder of Equasens Société?
Currently, no hedge funds are holding shares in DE:PHF
Company Description
Equasens Société
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
PHF Stock 12 Month Forecast
Average Price Target
€75.00
▲(84.50%Upside)
Technical Analysis
Bastide le Confort Medical
―
Cegedim
―
LNA Sante SA
―
Ramsay Generale de Sante
―
Eurobio-Scientific SA
―